Connect with us

News

Tender awarded even before Cabinet decision

Published

on

Procurement of fake Immunoglobulin:

Ex-State Minister says this particular medicine cannot be produced here

By Shamindra Ferdinando

Samagi Jana Balawegaya (SJB) parliamentarian Kavinda Jayawardana yesterday (20) said that the Wickremesinghe-Rajapaksa government fiercely protected those who had been responsible for a spate of corrupt deals at the Health Ministry.

The recent arrest of former Health Secretary Janaka Sri Chandragupta over the procurement of fake Immunoglobulin by the Ministry was just one of many corrupt deals, the Gampaha District lawmaker told The Island.

The Parliament on 08 Sept., 2023 defeated a no-confidence motion moved against Health Minister Keheliya Rambukwella, thereby allowing the sordid operations to continue, he said.

“The SLPP saved Minister Rambukwella,” Jayawardana said, adding that 113 MPs who voted against the no-faith motion and 38 absentees at the time of the voting, following a three-day debate, owed the country an esplanation.

MP Jayawardana emphasised that the arrested Health Secretary had been the Chief Accounting Officer of that particular Ministry and also functioned as the head of the Health Sector Emergency Procurement Committee (HSEPC).

At the time of his arrest, Chandragupta, a Special Grade Officer in the Sri Lanka Administrative Service, was on retirement. Chandragupta received the appointment as Health Secretary on May 24, 2022 close on the heels of Premier Mahinda Rajapaksa’s resignation.

Former Director General of Health Services and one time additional Secretary, Dr. Palitha Maheepala was brought in November this year as Chandragupta’s successor.

Responding to another query, MP Jayawardena said that about a week before the Parliament voted on the no-confidence motion against Minister Rambukwella, he along with Gampaha District colleague Harshana Rajakaruna filed a fundamental rights petition targeting the Minister concerned and several senior officials, including Chairman NMRA (National Medicine Regulatory Authority) and DGHS (Director General of Health Services).

Health sector sources said that the Criminal Investigation Department (CID) arrested Director, Medical Supplies Division Dr. Kapila Wickremenayake, Assistant Director Devashantha Soloman, Accountant (Supplies) Neran Dhananjaya and the Stock Controller of the Medical Supplies Division Sujith Kumara in connection with the high profile scam on Nov 20, the day Chandragupta retired, having reached the mandatory retirement age of 60 years.

About a week after their arrest the CID recorded a statement from Finance Secretary Mahinda Siriwardana in connection with the ongoing investigation. Chandragupta was taken into custody about three weeks later.

Arrested on Dec 18, Chandragupta was remanded till Dec 17 by Maligakanda Magistrate Lochana Abeywickrema pending further investigations.

Former State Health Minister Prof. Channa Jayasumana told The Island that some authorities, including police and a section of the media erroneously claimed that the ongoing investigation centered on the import of substandard Immunoglobulin vials.

The CID arrested Aruna Deepthi, the 57-year-old proprietor of Isolez Biotech Pharma on Oct 31 for supplying fake Immunoglobulin vials.

Prof. Jayasumana emphasized that Sri Lanka lacked the knowhow and the technology to produce Immunoglobulin vials under any circumstances. But, the government had accepted Isolez Biotech Pharma as a local producer capable of producing the Immunoglobulin vials thereby abusing the Indian credit line that was meant to import a range of items from India, including medicine.

Some concerned parties, including Ravi Kumudesh, President, College of Medical Laboratory Science, Dr. Rukshan Bellana, President, Government Medical Officers’ Forum and Dr. Chamal Sanjeewa, President of the Medical and Civil Rights Professional Association took up health sector corruption.

Prof. Jayasumana said that the Immunoglobulin controversy had caused irreparable damage to the country’s image. “Whatever the problems, our health service was considered in line with Western standards,” Prof. Jayasumana said, urging the government to punish those responsible, regardless of their standing in society.

The Immunoglobulin issue came to light following reports of allergic reactions after the drug was administered to several patients being treated at the Colombo National Hospital and the Matale District Hospital on August 22 and September 16, respectively. Academy of Health Professionals on November 05 alleged that blood required for the production of the fake Immunoglobulin vials had been obtained from the National Blood Transfusion Service (NBTS).

Deputy Solicitor General Lakmini Girihagama appearing with Senior State Counsel Heshani Wijesinghe making submissions earlier on the progress of the CID investigations has told Maligakanda Magistrate Court that prior to the Cabinet decision taken in October 2022, tenders had been called in September 2022 and the 1st suspect Aruna Deepthi had been selected as the successful tenderer for Human Immunoglobulin and Rituximab.

She said according to the Ministry Chief Accountant Savidra Cooray the 1st suspect’s company Isolez Biotech Pharma had requested for payments for Rituximab supplied and the Secretary Health Chandragupta had approved the payment of Rs 107,799,481/= in three payments to the 1st suspect, directing it to be paid on a priority basis.

However, the CID arrested Director, Medical Supplies Division Dr. Kapila Wickremenayake, who hadn’t been even attached to the unit at the time, but away in the UK from January to Dec 2022, in connection with the inquiry.

Dr. Bellana said that one of those doctors directly involved in the corrupt procurement process had fled the country. That doctor served as an Additional Secretary in charge of emergency procurement who wielded power as he happened to be a brother of a sitting ruling party MP, Dr. Bellana said. The trade union activist stressed that he didn’t imply the involvement of the MP whatsoever in the scam, but pointed out the need to conduct a no holds barred investigation.

The Additional Secretary had been also under investigation and the matter was also brought to the notice of the Maligakanda court, Dr. Bellana said, urging the government not to play politics with this issue.

Maligakanda Magistrate on Monday (18) ordered the office of Additional Secretary to the Health Ministry Dr. Saman Ratnayake sealed. Dr. Bellana said that the Doctor who fled the country had been an aide to Dr. Ratnayake, who held several other posts.

Dr. Bellana said that Minister Rambukwella couldn’t wash his hands of the developing situation as he, through a Cabinet paper, created the post of Additional Secretary, Emergency procurement to accommodate Dr. Ratnayake.



News

Breakaway JVP faction decries Indo-Lanka MoUs as betrayal

Published

on

Pubudu

… alleges Kanchana’s Electricity Act exploited to facilitate ‘deal’ with India

The Frontline Socialist Party (FSP) has alleged that President Anura Kumara Dissanayake entered into seven MoUs/Agreements with India without consulting Parliament or the Cabinet of Ministers.

Accusing President Anura Kumara Dissanayake, who is the leader of the Janatha Vimukthi Peramuna (JVP), as well as the National People’s Power (NPP), of undermining Sri Lanka’s sovereignty, the breakaway JVP faction pointed out the signing of seven MoUs/Agreements had coincided with the 54th anniversary of the JVP’s first insurrection.

The top FSP spokesman and their Education Secretary, Pubudu Jayagoda, told a press conference, at their Nugegoda party office, that the JVP had completely betrayed those who sacrificed their lives during the 1971 and 1987-1990 insurrections. Having completely changed its policy towards India, the JVP was now down on its knees before India, Jayagoda said.

The dissident JVPer emphasised that such vital MoUs/Agreements couldn’t be finalised without proper consultations. Declaring that the MoUs/Agreements hadn’t been released yet, Jayagoda said that the FSP, in terms of the Right to Information Act, sought the copies of them as the public couldn’t be deprived of their right to know.

The section, now calling themselves FSP, split from the JVP in early 2012 after major differences among the top leadership over the direction of the party. Anura Kumara Dissanayake succeeded Somawansa Amarasinghe as the JVP leader in Dec. 2014.

Referring to the MoU, in respect of the implementation of HVDC interconnection for import/export of power, Jayagoda said that the NPP took advantage of the new Electricity Act that was enforced by the Wickremesinghe-Rajapaksa government in late June last year to pave the way for a deal with India. The JVP-led NPP that moved court against the then Power Minister Kanchana Wijesekera’s Bill, and voted against the Bill at the second reading, exploited the same to its advantage, Jayagoda charged.

The Sri Lanka Electricity Bill repealed the 1969 Ceylon Electricity Board (CEB) Act and subsequent laws regarding the electricity industry.

Comparing the MoU, signed in the presence of President Dissanayake and Premier Narendra Modi, Jayagoda said that both Nepal and Bangladesh had been trapped in similar agreements they signed earlier.

Jayagoda alleged that Nepal was in such a pathetic situation even if they could meet electricity requirement through hydro-power generation, the agreement with India compelled them to obtain power from India.

Jayagoda pointed out that the government now boasted of a proposed new120 MW solar power plant at Sampur to be implemented in two stages after having crippled domestic solar power generation capacity. The former JVPer said that the NPP government was bending backwards to appease India and pursuing an agenda inimical to Sri Lanka.

Jayagoda dealt with the MoU on cooperation in the field of sharing successful digital solutions implemented at population scale for digital transformation. The FSP spokesman said that the Indian-funded project to issue digital NIC would be disastrous as it would enable India to gather information.

Commenting on a MoU that covered the health sector, Jayagoda alleged that the government had agreed to share authority exercised by the National Medicine Regulatory Authority (NMRA) with India.

Jayagoda said that the MoU on defence cooperation undermined the country’s vital security interests and jeopardised relations with other countries.

The FSP said that political parties, represented in Parliament, were largely silent and seemed to be reluctant at least to express their views on the betrayal of the country.

By Shamindra Ferdinando

Continue Reading

News

Adani’s Colombo Terminal commences operations

Published

on

A bulk carrier at the newly operational Colombo West terminal(pic courtesy Adani group)

Adani Ports and Special Economic Zone Ltd. (APSEZ), India’s largest integrated transport utility, has announced the commencement of operations at the Colombo West International Terminal (CWIT), located at the Port of Colombo, the company said in a statement issued simultaneously in Ahmedabad and Colombo yesterday (07)

Developed under a landmark public–private partnership, CWIT is operated by a consortium comprising India’s largest port operator Adani Ports & SEZ Ltd., leading Sri Lankan conglomerate John Keells Holdings PLC, and the Sri Lanka Ports Authority, under a 35-year Build, Operate, and Transfer (BOT) agreement.

The CWIT project represents a significant investment of USD 800 million and features a 1,400-metre long quay and 20-metre depth, enabling the terminal to handle approximately 3.2 million Twenty-foot Equivalent Units (TEUs) annually. It is the first deep-water terminal in Colombo to be fully automated, designed to enhance cargo handling capabilities, improve vessel turnaround times and elevate the port’s status as a key transshipment hub in South Asia.

Construction began in early 2022 and has since achieved rapid progress. With the installation of cutting-edge infrastructure now nearing completion, CWIT is poised to set new benchmarks in operational efficiency and reliability in regional maritime logistics.

“The commencement of operations at CWIT marks a momentous milestone in regional cooperation between India and Sri Lanka,” said Chairman of the Adani Group Gautam Adani. “Not only does this terminal represent the future of trade in the Indian Ocean but its opening is also a proud moment for Sri Lanka, placing it firmly on the global maritime map. The CWIT project will create thousands of direct and indirect jobs locally and unlock immense economic value for the island nation. It also stands as a shining example of the deep-rooted friendship and growing strategic ties between the two neighbours, and of what can be achieved through visionary public–private partnerships. Delivering this world-class facility in record time also reflects the Adani Group’s proven ability to efficiently execute large-scale critical infrastructure projects anywhere in the world.”

“We are proud to see the progress in the development of the West Container Terminal, a project that strengthens Sri Lanka’s position as a regional maritime hub,” said Chairperson, John Keells Group Krishan Balendra. “This project is one of the John Keells Group’s largest investments and is among the most significant private-sector investments in Sri Lanka. Together with the Sri Lanka Ports Authority and the Adani Group, we will elevate Colombo’s status as a leading transshipment hub. We are confident that the project will enhance global trade and connectivity in the region”, he said.

Continue Reading

News

SLIC Life reports robust performance with Rs. 30.7 Billion PBT in 2024

Published

on

Nusith Kumaratunga (L) / Chandana L. Aluthgama (R)

Sri Lanka Insurance Corporation Life Limited (SLICLL) has concluded the year 2024 with outstanding financial performance, achieving a remarkable profit before taxation of Rs. 30.7 billion. The text of SLIC statement: “The company recorded a robust Gross Written Premium (GWP) of Rs. 26.3 billion, reflecting an impressive 25% growth. Remarkably, as of December 31, 2024, Sri Lanka Insurance Life marked a historic milestone with a New Business volume of Rs. 5.3 billion, recording a 48% growth, the highest in the company’s history.

Demonstrating its unwavering commitment to policyholders, Sri Lanka Insurance Life disbursed Rs. 13.7 billion in maturity settlements and claim payments in 2024, these figures reaffirm the company’s financial strength and dedication to fulfilling its obligations. Further cementing its position as a market leader, SLICLL continued to expand its asset base to an impressive Rs. 237 billion and grew its Life Fund to Rs. 213.2 billion. These achievements were realised amidst organizational transformations and challenging economic conditions. Additionally, the company recorded 319 MDRT qualifiers, the highest ever for SLIC Life.

Highlighting its prudent investment strategies and unwavering commitment to policyholders, Sri Lanka Insurance Life declared the largest Life Insurance bonus in the industry for 2023, amounting to Rs. 11.2 billion. Over the past two decades, the company has consistently delivered industry-leading bonus payouts, with cumulative declarations exceeding Rs. 104 billion. Continuing this legacy, Sri Lanka Insurance Life is set to declare its highest ever bonus for 2024, with official communication to be released in the near future.

Group Chief Executive Officer of Sri Lanka Insurance, Mr. Chandana L. Aluthgama, stated, “Our exceptional financial performance is a testament to the dedication and resilience of our team, who have navigated challenges with unwavering commitment. Despite economic fluctuations and internal transformations, our strategic focus has reinforced our market leadership. As we step into the future, we remain committed to innovation, customer trust, and industry leadership.”

Chairman of Sri Lanka Insurance, Mr. Nusith Kumaratunga, emphasized, “Sri Lanka Insurance Life has proven its strength and stability, delivering sustainable growth while reinforcing its role in the nation’s economic progress. Our vision extends beyond business success, we aim to contribute to national development by strengthening the economy and reducing dependency of the people on state support.”

Beyond financial success, Sri Lanka Insurance Life continued to earn industry recognition in 2024. The company was named ‘The Most Loved Life Insurance Brand’ by LMD for the seventh consecutive year and was ranked among the ‘Top 100 Most Valuable Brands’ in Sri Lanka by LMD Brand Finance. Additionally, SLIC Life secured top honors at the ‘Best Management Practices Company Awards 2024,’ ranking among the top ten companies and winning the ‘Insurance – Public Sector Company’ category.

Committed to international standards and operational excellence, Sri Lanka Insurance Life maintains ISO 9001:2015, ISO/IEC 27001:2013, and ISO 14064-1:2018 certifications. The company also continues its social impact initiatives, including the free Life Insurance cover gifted to parents of newborns on World Children’s Day for the third consecutive year, supported 1100 families in flood affected areas, providing emergency assistance to pilgrims traveling to Anuradhapura for Poson Poya and the awarding of 370 Suba Pathum scholarships to outstanding students in national examinations.

Looking ahead, Sri Lanka Insurance Life remains focused on driving innovation, enhancing customer confidence, and making meaningful contributions to society. With a solid foundation and a clear vision, the company is poised to maintain its legacy of excellence and leadership in the insurance industry.

.

Continue Reading

Trending